Ron Handels

3.5k total citations · 1 hit paper
61 papers, 1.0k citations indexed

About

Ron Handels is a scholar working on Psychiatry and Mental health, Economics and Econometrics and General Health Professions. According to data from OpenAlex, Ron Handels has authored 61 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Psychiatry and Mental health, 36 papers in Economics and Econometrics and 20 papers in General Health Professions. Recurrent topics in Ron Handels's work include Dementia and Cognitive Impairment Research (38 papers), Health Systems, Economic Evaluations, Quality of Life (36 papers) and Geriatric Care and Nursing Homes (12 papers). Ron Handels is often cited by papers focused on Dementia and Cognitive Impairment Research (38 papers), Health Systems, Economic Evaluations, Quality of Life (36 papers) and Geriatric Care and Nursing Homes (12 papers). Ron Handels collaborates with scholars based in Netherlands, Sweden and United Kingdom. Ron Handels's co-authors include Anders Wimo, Frans R.J. Verhey, Claire Wolfs, Pieter Jelle Visser, Pauline Aalten, Linus Jönsson, Bengt Winblad, Stephanie J. B. Vos, Johan L. Severens and Ineke A. van Rossum and has published in prestigious journals such as European Heart Journal, Journal of Psychosomatic Research and Journal of Internal Medicine.

In The Last Decade

Ron Handels

57 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The affordability of lecanemab, an amyloid-targeting therapy for Alzheimer's disease: an EADC-EC viewpoint

2023 75 citations Linus Jönsson, Anders Wimo et al. The Lancet Regional Health - Europe profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ron Handels Netherlands	17	630	329	279	224	104	61	1.0k
Kristin Kahle‐Wrobleski United States	19	624 1.0×	255 0.8×	129 0.5×	288 1.3×	116 1.1×	44	1.2k
Katrin Seeher Australia	17	734 1.2×	215 0.7×	109 0.4×	366 1.6×	105 1.0×	34	1.3k
Heather Davila United States	10	372 0.6×	185 0.6×	92 0.3×	273 1.2×	109 1.0×	45	935
J. Scott Andrews United States	16	823 1.3×	569 1.7×	232 0.8×	132 0.6×	121 1.2×	44	1.5k
Guk‐Hee Suh South Korea	17	531 0.8×	182 0.6×	106 0.4×	205 0.9×	92 0.9×	51	828
Edgar Nunes de Moraes Brazil	21	397 0.6×	275 0.8×	114 0.4×	273 1.2×	169 1.6×	85	1.3k
J.-F. Dartigues France	12	521 0.8×	449 1.4×	180 0.6×	252 1.1×	374 3.6×	21	1.4k
Marcel Olde‐Rikkert Netherlands	16	368 0.6×	286 0.9×	77 0.3×	223 1.0×	87 0.8×	28	1.2k
Eugene Tang United Kingdom	14	653 1.0×	147 0.4×	89 0.3×	194 0.9×	99 1.0×	59	1.2k
Suzanne A. Ligthart Netherlands	15	553 0.9×	217 0.7×	85 0.3×	189 0.8×	106 1.0×	31	974

Countries citing papers authored by Ron Handels

Since Specialization

Citations

This map shows the geographic impact of Ron Handels's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ron Handels with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ron Handels more than expected).

Fields of papers citing papers by Ron Handels

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ron Handels. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ron Handels. The network helps show where Ron Handels may publish in the future.

Co-authorship network of co-authors of Ron Handels

This figure shows the co-authorship network connecting the top 25 collaborators of Ron Handels. A scholar is included among the top collaborators of Ron Handels based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ron Handels. Ron Handels is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hoevenaar‐Blom, Marieke P., et al.. (2025). mHealth Intervention for Dementia Prevention through lifestyle Optimisation (MIND-PRO) in a primary care setting: protocol for a randomised controlled trial in people with low SES and/or migration background. BMJ Open. 15(2). e088324–e088324. 1 indexed citations

Wimo, Anders, Ron Handels, Kaj Blennow, et al.. (2025). Cost-effectiveness of diagnosing and treating patients with early Alzheimer's disease with anti-amyloid treatment in a clinical setting. Journal of Alzheimer s Disease. 104(4). 1167–1184. 4 indexed citations

Wolters, Frank J., et al.. (2024). Comparing the short‐term and long‐term impact of primary and secondary prevention strategies on population‐level dementia burden: A microsimulation modelling study. Alzheimer s & Dementia. 20(S7).

Mendes, Aline, François R. Herrmann, Sverre Bergh, et al.. (2024). Clinical Predictors of Mortality in People with Severe Behavioral and Psychological Symptoms of Dementia. Journal of the American Medical Directors Association. 26(2). 105374–105374. 3 indexed citations

Handels, Ron, Sabine Grimm, Arjan Blokland, et al.. (2023). The value of maintaining cognition in patients with mild cognitive impairment: The innovation headroom and potential cost‐effectiveness of roflumilast. Alzheimer s & Dementia. 19(8). 3458–3471. 4 indexed citations

Bouteloup, Vincent, Ashley Tate, Anders Wimo, et al.. (2023). Health-related quality of life in subjective cognitive decline and mild cognitive impairment: a longitudinal cohort analysis. Alzheimer s Research & Therapy. 15(1). 200–200. 8 indexed citations

Mendes, Aline, Sverre Bergh, Bruno Mario Cesana, et al.. (2023). Respectful Caring for the Agitated Elderly (ReCAGE): A Multicentre, Prospective, Observational Study to Evaluate the Effectiveness of Special Care Units for People with Dementia. Journal of Alzheimer s Disease. 96(3). 1083–1096. 2 indexed citations

Jönsson, Linus, Anders Wimo, Ron Handels, et al.. (2023). The affordability of lecanemab, an amyloid-targeting therapy for Alzheimer's disease: an EADC-EC viewpoint. The Lancet Regional Health - Europe. 29. 100657–100657. 75 indexed citations breakdown →

Cognat, Emmanuel, Sèverine Sabia, Alexandra Fayel, et al.. (2023). BPSD Patterns in Patients With Severe Neuropsychiatric Disturbances: Insight From the RECAGE Study. American Journal of Geriatric Psychiatry. 31(8). 633–639. 5 indexed citations

10.

Wimo, Anders, Ron Handels, Riitta Antikaínen, et al.. (2022). Dementia prevention: The potential long‐term cost‐effectiveness of the FINGER prevention program. Alzheimer s & Dementia. 19(3). 999–1008. 25 indexed citations

11.

Janssen, Niels, Ron Handels, Anders Wimo, et al.. (2022). Association Between Cognition, Health Related Quality of Life, and Costs in a Population at Risk for Cognitive Decline. Journal of Alzheimer s Disease. 89(2). 623–632. 4 indexed citations

12.

Huygens, Simone, et al.. (2022). Costs of Persons with Dementia Living in Nursing Homes in The Netherlands. Journal of Alzheimer s Disease. 89(1). 359–366. 2 indexed citations

13.

Stephan, Astrid, Maria J. Marques, Anja Bieber, et al.. (2021). Self- and proxy-rating of the ICECAP-O for people with dementia: A cross-sectional linguistic validation study in Germany and Portugal. Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen. 162. 24–31. 2 indexed citations

14.

Wolfs, Claire, Marieke Perry, Job Metsemakers, et al.. (2021). Implementation of a diagnostic decision aid for people with memory complaints and their general practitioners: a protocol of a before and after pilot trial. BMJ Open. 11(6). e049322–e049322. 4 indexed citations

15.

Janssen, Olin, Stephanie J. B. Vos, Ron Handels, et al.. (2020). Duration of Care Trajectories in Persons With Dementia Differs According to Demographic and Clinical Characteristics. Journal of the American Medical Directors Association. 21(8). 1102–1107.e6. 8 indexed citations

16.

Janssen, Niels, Ron Handels, Sebastian Köhler, et al.. (2020). Profiles of Met and Unmet Needs in People with Dementia According to Caregivers’ Perspective: Results from a European Multicenter Study. Journal of the American Medical Directors Association. 21(11). 1609–1616.e1. 11 indexed citations

17.

Kerpershoek, Liselot, Marjolein de Vugt, Claire Wolfs, et al.. (2019). Is there equity in initial access to formal dementia care in Europe? The Andersen Model applied to the Actifcare cohort. International Journal of Geriatric Psychiatry. 35(1). 45–52. 20 indexed citations

18.

Landeiro, Filipa, Katie Walsh, Isaac Ghinai, et al.. (2018). Measuring quality of life of people with predementia and dementia and their caregivers: a systematic review protocol. BMJ Open. 8(3). e019082–e019082. 15 indexed citations

19.

Janssen, Niels, Ron Handels, Inez H.G.B. Ramakers, et al.. (2016). Combinations of Service Use Types of People With Early Cognitive Disorders. Journal of the American Medical Directors Association. 17(7). 620–625. 8 indexed citations

20.

Handels, Ron, Claire Wolfs, Pauline Aalten, Frans R.J. Verhey, & Johan L. Severens. (2012). Determinants of Care Costs of Patients With Dementia or Cognitive Impairment. Alzheimer Disease & Associated Disorders. 27(1). 30–36. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact